It's that time again! Jim Cramer rang the lightning round bell, which means he gave his take on caller favorite stocks at rapid speed:
Palo Alto Networks: "The quarter was really good, the stock had a very big move. It is now consolidating and I think it is ready to go higher."
Rite Aid: "Two ways to win here. Walgreen's which has a big position in the charitable trust, either they are going to close the deal and you will make money. Or if they walk away I think there are other buyers. I like Rite Aid, but I do prefer Walgreen's."
Entergy Corp: "It's too darned cheap at 4.6 percent yield, I know that right now they don't like those interest rate sensitives. But what goes around comes around."
Read more from Mad Money with Jim Cramer
Relypsa on FDA approval for Veltassa: "Yes I didn't didn't read the acceptance of it as being that positive at all. And they have to do a label change. I didn't read it the way you did, I just did not think it was that positive."
Intercept Pharmaceuticals: "Small, speculative biotechs have still not come back. They just haven't, and I'm not going to go there yet until I see some pulse — and I don't."